• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板生成素依赖性巨核细胞系UT-7/TPO的建立与鉴定

Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

作者信息

Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Miura Y

机构信息

Division of Hematology, Department of Medicine, Jichi Medical School, Tochigi, Japan.

出版信息

Blood. 1996 Jun 1;87(11):4552-60.

PMID:8639823
Abstract

UT-7 is a human megakaryoblastic leukemia cell line with absolute dependence on interleukin-3, granulocyte-macrophage colony-stimulating factor, or erythropoietin (EPO) for growth and survival. We investigated the effect of thrombopoietin (TPO), the ligand for the receptor encoded by c-mpl proto-oncogene, on the proliferation and differentiation of UT-7 and its sublines. We found that UT-7/GM, which is a subline of UT-7, but neither UT-7 nor UT-7/EPO, can proliferate in response to TPO. The subline, UT-7/TPO, was established from UT-7/GM by culture at lower concentrations of TPO. UT-7/TPO cells had morphologically mature megakaryocytic characteristics such as developed demarcation membrane in the cytoplasm and multinucleated appearance. This was also confirmed by the high expression of platelet factor-4 and glycoprotein IIb at the mRNA levels and by the high level of DNA content. UT-7/TPO can be maintained by TPO alone, with a doubling time of 24 hours in log growth phase. In the absence of TPO, the majority of the cells died within a few days. Thus, UT-7/TPO has an absolute dependence on TPO for growth and survival and has mature megakaryocytic features. The mRNA for c-mpl was detected in UT-7/TPO and, to a lesser degree, in UT-7/GM. The mRNA level of NF- E2 p45, reported to be an erythroid-specific transcription factor, was upregulated in UT-7/TPO, whereas it was down-regulated in the erythroid subline, UT-7/EPO. There were no significant differences in GATA-1 and GATA-2 mRNA levels among UT-7 and its sublines. Not only EPO but also TPO induced the tyrosine phosphorylation of JAK2 tyrosine kinase and STAT5-related protein. These findings indicate that UT-7/TPO would be a useful model with which to analyze the gene regulation of megakaryocytic maturation-associated proteins and to study the specific actions of TPO.

摘要

UT-7是一种人巨核细胞白血病细胞系,其生长和存活绝对依赖于白细胞介素-3、粒细胞-巨噬细胞集落刺激因子或促红细胞生成素(EPO)。我们研究了血小板生成素(TPO)(c-mpl原癌基因编码的受体的配体)对UT-7及其亚系增殖和分化的影响。我们发现,UT-7的一个亚系UT-7/GM能够对TPO产生增殖反应,但UT-7和UT-7/EPO均无此反应。UT-7/TPO亚系是通过在较低浓度的TPO中培养从UT-7/GM建立的。UT-7/TPO细胞具有形态学上成熟的巨核细胞特征,如细胞质中发达的分界膜和多核外观。这也通过血小板因子-4和糖蛋白IIb在mRNA水平的高表达以及高DNA含量得到证实。UT-7/TPO仅在TPO存在下就能维持生长,对数生长期的倍增时间为24小时。在没有TPO的情况下,大多数细胞在几天内死亡。因此,UT-7/TPO的生长和存活绝对依赖于TPO,并具有成熟的巨核细胞特征。在UT-7/TPO中检测到了c-mpl的mRNA,在UT-7/GM中也有较低程度的表达。据报道,作为一种红系特异性转录因子的NF-E2 p45的mRNA水平在UT-7/TPO中上调,而在红系亚系UT-7/EPO中下调。UT-7及其亚系之间GATA-1和GATA-2的mRNA水平没有显著差异。不仅EPO,而且TPO都能诱导JAK2酪氨酸激酶和STAT5相关蛋白的酪氨酸磷酸化。这些发现表明,UT-7/TPO将是一个有用的模型,可用于分析巨核细胞成熟相关蛋白的基因调控以及研究TPO的具体作用。

相似文献

1
Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.血小板生成素依赖性巨核细胞系UT-7/TPO的建立与鉴定
Blood. 1996 Jun 1;87(11):4552-60.
2
Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.血小板生成素对红系分化的抑制作用以及对巨核系分化的诱导作用,在依赖血小板生成素的UT-7/c-mpl和TF-1/c-mpl细胞系中是由两种不同机制调控的。
Leukemia. 1998 Sep;12(9):1355-66. doi: 10.1038/sj.leu.2401122.
3
Thrombopoietin activates a STAT5-like factor in hematopoietic cells.血小板生成素激活造血细胞中的一种STAT5样因子。
EMBO J. 1995 Jun 15;14(12):2847-56. doi: 10.1002/j.1460-2075.1995.tb07284.x.
4
The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.重组人血小板生成素在急性髓性白血病细胞增殖和巨核细胞分化中的生物学特性。
Blood. 1996 Oct 15;88(8):3074-82.
5
Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.纤溶酶原激活物抑制剂-1的发育性表达与血小板生成素依赖性巨核细胞分化相关。
Blood. 1999 Jul 15;94(2):475-82.
6
Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.血小板生成素通过其在人白血病细胞系中的特异性受体c-Mpl支持体外红系分化。
Cell Growth Differ. 1998 Jun;9(6):487-96.
7
Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.JAK2/STAT5信号转导通路的组成性激活与巨核细胞白血病细胞系的生长因子非依赖性相关。
Blood. 1999 Apr 1;93(7):2369-79.
8
Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.延长的ras激活参与血小板生成素诱导的人因子依赖性造血细胞系巨核细胞分化。
Mol Cell Biol. 1998 Jul;18(7):4282-90. doi: 10.1128/MCB.18.7.4282.
9
In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM.源自UT-7亚系UT-7/GM的红系和巨核系细胞的体外发育
Blood. 1997 Jun 1;89(11):4021-33.
10
Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.血小板生成素、白细胞介素-3及激酶抑制剂K-252a对巨核细胞系M-07e生长和多倍体化的影响
Leukemia. 1998 Oct;12(10):1603-11. doi: 10.1038/sj.leu.2401170.

引用本文的文献

1
Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy.人骨髓间充质干细胞衍生的外泌体作为柔红霉素的工程载体用于靶向c-Mpl+急性髓系白血病治疗
Int J Nanomedicine. 2025 Apr 24;20:5267-5289. doi: 10.2147/IJN.S511713. eCollection 2025.
2
The Role of Mutated Calreticulin in the Pathogenesis of -Negative Myeloproliferative Neoplasms.突变钙网织蛋白在 - 阴性骨髓增殖性肿瘤发病机制中的作用。
Int J Mol Sci. 2024 Sep 12;25(18):9873. doi: 10.3390/ijms25189873.
3
Thrombopoietin-independent generation of platelet-like particles from megakaryoblastic cells.
巨核细胞来源的血小板样颗粒的促血小板生成素非依赖性生成。
Sci Rep. 2023 Dec 18;13(1):22553. doi: 10.1038/s41598-023-50111-6.
4
Quantitative systems pharmacology model of thrombopoiesis and platelet life-cycle, and its application to thrombocytopenia based on chronic liver disease.血小板生成和血小板生命周期的定量系统药理学模型,及其在基于慢性肝脏疾病的血小板减少症中的应用。
CPT Pharmacometrics Syst Pharmacol. 2021 May;10(5):489-499. doi: 10.1002/psp4.12623. Epub 2021 May 3.
5
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.同源二聚体细胞因子受体的激活机制及致癌突变的失调。
Science. 2020 Feb 7;367(6478):643-652. doi: 10.1126/science.aaw3242.
6
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.巨核细胞中突变钙网蛋白与 SOCE 的缺陷相互作用与骨髓增殖性肿瘤。
Blood. 2020 Jan 9;135(2):133-144. doi: 10.1182/blood.2019001103.
7
DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells.DLGAP1以依赖MPL的方式在造血细胞中指导巨核细胞的生长和分化。
Biomark Res. 2019 Jul 8;7:13. doi: 10.1186/s40364-019-0165-z. eCollection 2019.
8
Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.新型血小板生成素受体激动剂TA-316有助于人诱导多能干细胞生成血小板。
Blood Adv. 2017 Feb 28;1(7):468-476. doi: 10.1182/bloodadvances.2016000844.
9
Gene editing rescue of a novel mutant associated with congenital amegakaryocytic thrombocytopenia.基因编辑挽救与先天性无巨核细胞血小板减少症相关的一种新型突变体。
Blood Adv. 2017 Sep 22;1(21):1815-1826. doi: 10.1182/bloodadvances.2016002915. eCollection 2017 Sep 26.
10
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.先天性巨核细胞血小板减少症伴血小板生成素突变可治疗性药物:罗米司亭。
EMBO Mol Med. 2018 Jan;10(1):63-75. doi: 10.15252/emmm.201708168.